Search Results

Catheter Closure for ASD

Transcatheter atrial septal defect (ASD) closure has become a widely recognized alternative to surgical closure for suitable secundum ASDs.

Device Therapy for Structural Heart Disease

This issue examines device therapy for structural heart disease.

IDE Approved for Trial of Carag’s Transcatheter Bioresorbable Septal Occluder

July 1, 2020—Carag AG, a Switzerland-based medical device company, announced it has received FDA investigational device exemption approval for the Carag bioresorbable septal occluder (CBSO), the company’s transcatheter septal occluder with a bioresorbable, metal-free framework.

atHeart Medical Commences Operations and Prepares Pivotal Trial of reSept ASD Occluder

April 20, 2021—atHeart Medical, a medical device company focused on closure of atrial septal defects (ASD), announced that it has commenced operations.